Meningiomas are one of those “you should never miss this on a vignette” diagnoses: extra-axial mass, dural attachment, slow-growing symptoms, and imaging clues that practically point an arrow at the answer. But the real USMLE skill is not just picking meningioma—it’s knowing why the other options are wrong based on the vignette details.
Clinical Vignette (Q-bank style)
A 52-year-old woman presents with 6 months of progressive headaches and intermittent focal seizures involving her right hand. She also reports a gradual change in personality and difficulty with planning at work. Neurologic exam shows mild right upper extremity weakness. MRI brain with contrast shows a well-circumscribed, extra-axial mass along the left frontal convexity with homogeneous enhancement and a “dural tail.” There is surrounding vasogenic edema with mild midline shift.
Most likely diagnosis?
A. Glioblastoma
B. Meningioma
C. Metastatic brain tumor
D. Oligodendroglioma
E. Vestibular schwannoma
Correct Answer: B. Meningioma
Why this is the best answer
This vignette screams extra-axial, dural-based tumor:
Key USMLE clues
- Demographics: middle-aged woman (female predominance)
- Symptoms: slowly progressive headaches, focal seizures, personality/executive dysfunction (frontal lobe compression), focal weakness
- Imaging:
- Extra-axial mass (often displaces cortex inward, CSF cleft may be seen)
- Homogeneous enhancement
- Dural tail sign = thickened enhancing dura adjacent to the tumor
- Vasogenic edema common (from mass effect)
High-yield path basics
- Origin: arachnoid cap (meningothelial) cells
- Histology: whorled pattern, psammoma bodies (laminated calcifications)
- Behavior: usually benign, but can compress adjacent brain
- Associations:
- NF2 (chromosome 22) → multiple meningiomas
- Prior cranial radiation increases risk
High-yield management pearls (Step 2 flavor)
- Symptomatic or growing: surgical resection
- Residual or unresectable: radiation (e.g., stereotactic radiosurgery)
- Edema/mass effect: dexamethasone can reduce vasogenic edema
- Seizures: treat with antiseizure meds (tumor-related seizures are common)
Why Each Distractor is Wrong (and what would make it right)
A. Glioblastoma
Why it’s wrong here
- Glioblastoma is typically intra-axial, infiltrative, and classically shows heterogeneous ring enhancement with central necrosis (“butterfly” crossing corpus callosum).
- Rapid progression is common; personality changes can occur, but imaging would not show a dural tail or classic extra-axial features.
What would point to glioblastoma
- Older adult with rapidly progressive neuro deficits
- MRI: ring-enhancing lesion with necrotic core, marked edema, possible crossing midline
- Path: pseudopalisading necrosis, microvascular proliferation
C. Metastatic brain tumor
Why it’s wrong here
- Metastases commonly lodge at the gray-white junction and are often multiple.
- Enhancement is frequently ring-enhancing, and lesions are intra-axial rather than dural-based (though dural metastases can occur—less classic than a meningioma).
What would point to metastases
- History of systemic cancer (esp. lung, breast, melanoma, RCC, colon)
- Multiple lesions with significant vasogenic edema
- Location at gray-white junction; variable enhancement patterns
Step tip: Multiple ring-enhancing lesions in an immunocompetent patient with known cancer → metastases until proven otherwise.
D. Oligodendroglioma
Why it’s wrong here
- Oligodendrogliomas are intra-axial cortical tumors, often in the frontal lobes, and can present with seizures—but the imaging hallmark is usually calcifications and a more infiltrative appearance, not a dural tail and extra-axial mass.
What would point to oligodendroglioma
- Adult with seizures
- Imaging: frontal lobe lesion with calcifications
- Genetics: codeletion, IDH mutation
- Path: “fried egg” cells and “chicken-wire” capillaries
E. Vestibular schwannoma
Why it’s wrong here
- Vestibular schwannomas arise at the cerebellopontine angle (CN VIII) and present with unilateral sensorineural hearing loss, tinnitus, and imbalance—not frontal lobe seizures and executive dysfunction.
What would point to vestibular schwannoma
- Progressive unilateral hearing loss ± tinnitus/vertigo
- MRI: enhancing CPA mass
- Association: NF2 (bilateral vestibular schwannomas are classic)
High-yield distinction: NF2 is linked to both schwannomas and meningiomas—location and symptoms tell you which tumor you’re dealing with.
Rapid Pattern Recognition Table (Exam-Useful)
| Tumor | Typical Age | Location | Imaging Hallmark | Classic Clues |
|---|---|---|---|---|
| Meningioma | Middle-aged adults, F > M | Extra-axial, dural | Homogeneous enhancement + dural tail | Whorls, psammoma bodies, NF2 |
| Glioblastoma | Older adults | Intra-axial, hemispheres | Ring enhancement + necrosis, may cross midline | Pseudopalisading necrosis |
| Metastases | Adults with cancer history | Gray-white junction | Often multiple, ring-enhancing | Lung/breast/melanoma/RCC/colon |
| Oligodendroglioma | Adults | Intra-axial, frontal | Calcifications, infiltrative | “Fried egg,” |
| Vestibular schwannoma | Adults | CPA (CN VIII) | Enhancing CPA mass | Unilateral SNHL, tinnitus; NF2 if bilateral |
High-Yield Takeaways (What to remember under pressure)
- Extra-axial + dural tail + homogeneous enhancement = meningioma until proven otherwise.
- Meningioma symptoms are often due to mass effect (headache, seizures, focal deficits).
- NF2 (chr 22) is a recurring association: meningiomas and vestibular schwannomas—use location/symptoms to differentiate.
- For ring-enhancing lesions, always think “metastasis vs glioblastoma vs abscess/toxo”—but in this vignette, the dural tail makes that differential less relevant.